日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Polyfunctional Mycobacterium tuberculosis-specific effector memory CD4+ T cells at sites of pleural TB.

胸膜结核病灶处的多功能结核分枝杆菌特异性效应记忆CD4+ T细胞

El Fenniri L, Toossi Z, Aung H, El Iraki G, Bourkkadi J, Benamor J, Laskri A, Berrada N, Benjouad A, Mayanja-Kizza H, Betts M R, El Aouad R, Canaday D H

Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein

合理设计一种能够重现与HIV-1包膜糖蛋白相互作用的CD4结合位点核心结构的微型蛋白

Vita, C; Drakopoulou, E; Vizzavona, J; Rochette, S; Martin, L; Ménez, A; Roumestand, C; Yang, Y S; Ylisastigui, L; Benjouad, A; Gluckman, J C

Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity

抗V3抗体反应性与HIV-1感染的临床分期和血清中和活性相关

Fenouillet, E; Blanes, N; Benjouad, A; Gluckman, J C

Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160

针对天然或去唾液酸化的1型人类免疫缺陷病毒重组gp160产生的抗体的特异性

Benjouad, A; Gluckman, J C; Montagnier, L; Bahraoui, E

Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160

碳水化合物部分对人类免疫缺陷病毒1型重组gp160免疫原性的影响

Benjouad, A; Gluckman, J C; Rochat, H; Montagnier, L; Bahraoui, E

Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1

人类免疫缺陷病毒1型tat蛋白神经毒性活性的证据

Sabatier, J M; Vives, E; Mabrouk, K; Benjouad, A; Rochat, H; Duval, A; Hue, B; Bahraoui, E